Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS Comput Biol. 2014 Jul 31;10(7):e1003741. doi: 10.1371/journal.pcbi.1003741. eCollection 2014 Jul.

Structure-based druggability assessment of the mammalian structural proteome with inclusion of light protein flexibility.

Author information

1
Schrödinger LLC, New York, New York, United States of America.
2
Amgen Inc., South San Francisco, California, United States of America.

Erratum in

  • PLoS Comput Biol. 2014 Sep;10(9):e1003875.

Abstract

Advances reported over the last few years and the increasing availability of protein crystal structure data have greatly improved structure-based druggability approaches. However, in practice, nearly all druggability estimation methods are applied to protein crystal structures as rigid proteins, with protein flexibility often not directly addressed. The inclusion of protein flexibility is important in correctly identifying the druggability of pockets that would be missed by methods based solely on the rigid crystal structure. These include cryptic pockets and flexible pockets often found at protein-protein interaction interfaces. Here, we apply an approach that uses protein modeling in concert with druggability estimation to account for light protein backbone movement and protein side-chain flexibility in protein binding sites. We assess the advantages and limitations of this approach on widely-used protein druggability sets. Applying the approach to all mammalian protein crystal structures in the PDB results in identification of 69 proteins with potential druggable cryptic pockets.

PMID:
25079060
PMCID:
PMC4117425
DOI:
10.1371/journal.pcbi.1003741
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center